TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Acasti Pharma Inc. (NASDAQ:ACST), are influenced by contrast since they are both players in the ...
Feeds
28393 items (28393 unread) in 74 feeds
Acinar Cell Carcinoma
(149 unread)
Acinic Cell Carcinoma
(118 unread)
Adenoid Cystic Carcinoma
(638 unread)
Adrenal Gland Cancer
(2386 unread)
Ampulla Of Vater
(684 unread)
Anal Cancer
(3004 unread)
Angiosarcoma
(893 unread)
Appendix Cancer
(375 unread)
Bile Duct Cancer
(3270 unread)
Brain and CNS
(3960 unread)
Carcinoid
(1208 unread)
Endocrine/Neuroendocrine
(3346 unread)
Gall Bladder Cancer
(1273 unread)
Hemangioendothelioma
(254 unread)
Hepatoblastoma
(466 unread)
Pancreas
(355 unread)
Phyllodes
(239 unread)
PMP and Mucinous Tumors
(280 unread)
Rhabdomyosarcoma
(1030 unread)
Sarcoma
(4465 unread)
Google - Angiosarcoma (100 unread)
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Acasti Pharma Inc. (NASDAQ:ACST) - Stocks Beat
Posted: June 18th, 2019, 12:01am GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Acasti Pharma Inc. (NASDAQ:ACST) Stocks Beat -
Angiosarcomas Treatment Market Influencing Factors by Top Companies - Business Herald
Posted: June 18th, 2019, 10:40pm GMT
Angiosarcomas Treatment Market Influencing Factors by Top Companies Business HeraldAngiosarcomas Treatment Market: The report provides a valuable source of insightful data for business strategists and competitive analysis of Angiosarcomas ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and InflaRx NV (NASDAQ:IFRX) - The NBO News
Posted: June 17th, 2019, 7:26pm GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and InflaRx NV (NASDAQ:IFRX) The NBO NewsThis is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and InflaRx N.V. (NASDAQ:IFRX) based on their risk, analyst recommendations,
-
Harvard Scientists Make 'Landmark' Discovery in Synthesizing Anti-Cancer Molecules Found in Sea Sponges - Gizmodo
Posted: June 17th, 2019, 5:20pm GMT
Harvard Scientists Make 'Landmark' Discovery in Synthesizing Anti-Cancer Molecules Found in Sea Sponges GizmodoHarvard and Japanese scientists say they've made a “landmark” discovery in cancer drug development. In a new study published Monday, they say they have ...
-
A Reversal for Athenex, Inc. (ATNX) Is Not Near. The Stock Declines Again - Invest Tribune
Posted: June 17th, 2019, 4:32pm GMT
A Reversal for Athenex, Inc. (ATNX) Is Not Near. The Stock Declines Again Invest TribuneThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock decreased 2.08% or $0.37 during the last trading session, reaching $17.43. About.
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Trevena Inc. (NASDAQ:TRVN) - Stocks Beat
Posted: June 17th, 2019, 10:52am GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Trevena Inc. (NASDAQ:TRVN) Stocks BeatAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Trevena Inc. (NASDAQ:TRVN), are affected by compare. This especially ...
-
What's in Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Rise in Shorted Shares? - The MAK Daily
Posted: June 16th, 2019, 4:57pm GMT
What's in Tracon Pharmaceuticals Inc (NASDAQ:TCON) After Rise in Shorted Shares? The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered an increase of 73.68% in short interest. TCON's total short interest was 430200 shares in.
-
Hundreds gather for hope, raising funds to help cancer patients - Scottsbluff Star Herald
Posted: June 16th, 2019, 4:00am GMT
Hundreds gather for hope, raising funds to help cancer patients Scottsbluff Star HeraldVolunteers at the Festival of Hope sported T-shirts, some red, some white, emblazoned with a saying, “Hope is a universal language.”
-
-$0.19 EPS Expected for TRACON Pharmaceuticals Inc (NASDAQ:TCON) This Quarter - Mayfield Recorder
Posted: June 15th, 2019, 7:43pm GMT
-$0.19 EPS Expected for TRACON Pharmaceuticals Inc (NASDAQ:TCON) This Quarter Mayfield RecorderAnalysts expect TRACON Pharmaceuticals Inc (NASDAQ:TCON) to announce ($0.19) earnings per share (EPS) for the current quarter, Zacks Investment ...
-
Light the Community - Jackson County Newspapers
Posted: June 15th, 2019, 1:55am GMT
Light the Community Jackson County NewspapersDinwiddie neighbors get together to raise funds for local families' medical expenses.
-
Light the Community - Keyser Mineral Daily News Tribune
Posted: June 15th, 2019, 1:54am GMT
Light the Community Keyser Mineral Daily News TribuneDinwiddie neighbors get together to raise funds for local families' medical expenses.
-
Neptune Wellness Solutions Inc. (NEPT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side - Stocks Beat
Posted: June 15th, 2019, 10:24pm GMT
Neptune Wellness Solutions Inc. (NEPT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side Stocks BeatBoth Neptune Wellness Solutions Inc. (NASDAQ:NEPT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete on a level playing field in the ...
-
Angiosarcomas Treatment Market Opportunities and Drivers Value Chain and Sales Channels Analysis Forecast 2026 - Forex Tribune
Posted: June 15th, 2019, 10:20pm GMT
Angiosarcomas Treatment Market Opportunities and Drivers Value Chain and Sales Channels Analysis Forecast 2026 Forex TribuneCoherent Market Insights study report on “Angiosarcomas Treatment Market by Size, Scope, Manufacturers, Applications, Types, Regions and Forecast to 2026”.
-
Nicolet Advisory Services LLC Acquires New Position in TRACON Pharmaceuticals Inc (NASDAQ:TCON) - Tech Know Bits
Posted: June 14th, 2019, 5:42am GMT
Nicolet Advisory Services LLC Acquires New Position in TRACON Pharmaceuticals Inc (NASDAQ:TCON) Tech Know BitsNicolet Advisory Services LLC bought a new position in shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) during the first quarter, according to its most ...
-
Light the Community - Progress Index
Posted: June 14th, 2019, 4:13am GMT
Light the Community Progress IndexCHURCH ROAD — A “Light the Community” fundraising dinner was held last weekend at the residence of Cody and Melissa Watkins to benefit the Gibbs and ...
-
Zacks: Brokerages Expect TRACON Pharmaceuticals Inc (NASDAQ:TCON) to Post -$0.19 EPS - Rockland Register
Posted: June 13th, 2019, 7:33pm GMT
Zacks: Brokerages Expect TRACON Pharmaceuticals Inc (NASDAQ:TCON) to Post -$0.19 EPS Rockland RegisterWall Street brokerages predict that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings per share (EPS) of ($0.19) for the current fiscal quarter, ...
-
Angiosarcomas Treatment Market Share, Revenue, and Average Price by Manufacturers Shared in a Latest Research Report - Truth Daily Mirror
Posted: June 13th, 2019, 9:03am GMT
Angiosarcomas Treatment Market Share, Revenue, and Average Price by Manufacturers Shared in a Latest Research Report Truth Daily MirrorLatest Industry Research Report On “Angiosarcomas Treatment – Industry Pipeline Insight, 2019” in-depth analysis of the market state and also the competitive ...
-
Could Athenex Inc (NASDAQ:ATNX) See a Reversal After Less Sellers Came In? - Invest Tribune
Posted: June 12th, 2019, 4:53pm GMT
Could Athenex Inc (NASDAQ:ATNX) See a Reversal After Less Sellers Came In? Invest TribuneThe stock of Athenex Inc (NASDAQ:ATNX) registered a decrease of 2.6% in short interest. ATNX's total short interest was 5.60 million shares in June as.
-
Angiosarcomas Treatment Market Exhibits Higher Growth Prospects during 2018-2026 - Veteran's Vista
Posted: June 12th, 2019, 9:11am GMT
Angiosarcomas Treatment Market Exhibits Higher Growth Prospects during 2018-2026 Veteran's VistaAngiosarcoma is a rare cancer of the inner lining of blood vessels, which occur in any area of the body, including the skin, breast, liver, spleen, and deep tissue ...
-
Angiosarcomas Treatment trends - Veteran's Vista
Posted: June 12th, 2019, 9:11am GMT
Angiosarcomas Treatment trends Veteran's VistaAngiosarcomas Treatment Market Exhibits Higher Growth Prospects during 2018-2026 | Key Players are Genentech, Inc., Pfizer Inc. Posted on June 12, 2019 ...
-
Angiosarcomas Treatment Market - Veteran's Vista
Posted: June 12th, 2019, 9:11am GMT
Angiosarcomas Treatment Market Veteran's VistaAngiosarcomas Treatment Market Exhibits Higher Growth Prospects during 2018-2026 | Key Players are Genentech, Inc., Pfizer Inc. Posted on June 12, 2019 ...
-
TRACON Pharmaceuticals Inc. (TCON) and Liquidia Technologies Inc. (NASDAQ:LQDA) Comparing side by side - The NBO News
Posted: June 12th, 2019, 11:22pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Liquidia Technologies Inc. (NASDAQ:LQDA) Comparing side by side The NBO NewsWe are contrasting TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Liquidia Technologies Inc. (NASDAQ:LQDA) on their dividends, institutional ownership ...
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Stock Is Shorted More - Invest Tribune
Posted: June 11th, 2019, 3:40pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Stock Is Shorted More Invest TribuneThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered an increase of 73.68% in short interest. TCON's total short interest was 430200 shares in.
-
Angiosarcomas Treatment Market Prophesied to Grow at a Faster Pace by 2026 - Business Herald
Posted: June 11th, 2019, 9:03am GMT
Angiosarcomas Treatment Market Prophesied to Grow at a Faster Pace by 2026 Business HeraldAngiosarcomas Treatment Market is a professional and detailed report focusing on primary and secondary drivers, market share, key segments and geographic ...
-
Orphan Drugs Market Competitive Analysis 2014-2022 and Key Players – AbbVie , Aegerion Pharmaceuticals, Bristol-Myers Squibb Company , Celgene Corporation - Honest Version
Posted: June 11th, 2019, 7:50am GMT
Orphan Drugs Market Competitive Analysis 2014-2022 and Key Players – AbbVie , Aegerion Pharmaceuticals, Bristol-Myers Squibb Company , Celgene Corporation Honest VersionThe pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs.
-
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share - Tech Know Bits
Posted: June 11th, 2019, 4:46am GMT
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share Tech Know BitsWall Street brokerages forecast that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings per share (EPS) of ($0.20) for the current quarter, ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and BioXcel Therapeutics Inc. (NASDAQ:BTAI) - The NBO News
Posted: June 10th, 2019, 5:11pm GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and BioXcel Therapeutics Inc. (NASDAQ:BTAI) The NBO NewsTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and BioXcel Therapeutics Inc. (NASDAQ:BTAI) compete against each other in the Biotechnology sector.
-
Mammography and MRI manifestations of breast angiosarcoma - BMC Blogs Network
Posted: June 10th, 2019, 1:02pm GMT
Mammography and MRI manifestations of breast angiosarcoma BMC Blogs NetworkBreast angiosarcoma is rare and previous studies only focus on its pathology. This study aimed to summarize its imaging features. Overall 17 patients ...
-
Steady Growth to be Witnessed by Soft Tissue Sarcoma Treatment Market by 2025 - Market Reporter
Posted: June 10th, 2019, 7:58am GMT
Steady Growth to be Witnessed by Soft Tissue Sarcoma Treatment Market by 2025 Market ReporterSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Abeona Therapeutics Inc. (ABEO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side - The NBO News
Posted: June 10th, 2019, 1:56am GMT
Abeona Therapeutics Inc. (ABEO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side The NBO NewsAbeona Therapeutics Inc. (NASDAQ:ABEO) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete with each other in the Biotechnology sector. We will ...
-
TRACON Pharmaceuticals Inc. (TCON) and Hoth Therapeutics Inc. (NASDAQ:HOTH) Comparing side by side - The NBO News
Posted: June 9th, 2019, 4:44am GMT
TRACON Pharmaceuticals Inc. (TCON) and Hoth Therapeutics Inc. (NASDAQ:HOTH) Comparing side by side The NBO NewsTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Hoth Therapeutics Inc. (NASDAQ:HOTH) are two firms in the Biotechnology that compete against each ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Molecular Templates Inc. (NASDAQ:MTEM)'s results - The NBO News
Posted: June 9th, 2019, 10:43pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Molecular Templates Inc. (NASDAQ:MTEM)'s results The NBO NewsTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Molecular Templates Inc. (NASDAQ:MTEM) compete against each other in the Biotechnology sector.
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) - The NBO News
Posted: June 8th, 2019, 1:56pm GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) The NBO NewsBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) are each other's competitor in the Biotechnology ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Announces Quarterly Earnings Results - Mayfield Recorder
Posted: June 8th, 2019, 11:41pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Announces Quarterly Earnings Results Mayfield RecorderTRACON Pharmaceuticals (NASDAQ:TCON) announced its earnings results on Tuesday, May 14th. The biopharmaceutical company reported ($0.24) earnings ...
-
Does Athenex Inc (NASDAQ:ATNX) Have Gas After Even Less Sellers Involved? - Invest Tribune
Posted: June 7th, 2019, 5:10pm GMT
Does Athenex Inc (NASDAQ:ATNX) Have Gas After Even Less Sellers Involved? Invest TribuneThe stock of Athenex Inc (NASDAQ:ATNX) registered a decrease of 2.6% in short interest. ATNX's total short interest was 5.60 million shares in June as.
-
TRACON Pharmaceuticals (NASDAQ:TCON) Posts Earnings Results, Misses Expectations By $0.03 EPS - Tech Know Bits
Posted: June 7th, 2019, 1:25am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Posts Earnings Results, Misses Expectations By $0.03 EPS Tech Know BitsTRACON Pharmaceuticals (NASDAQ:TCON) posted its quarterly earnings results on Tuesday, May 14th. The biopharmaceutical company reported ($0.24) ...
-
What Next for TRACON Pharmaceuticals, Inc. (TCON) After Forming Bearish Double Bottom Pattern? - The MAK Daily
Posted: June 6th, 2019, 4:02pm GMT
What Next for TRACON Pharmaceuticals, Inc. (TCON) After Forming Bearish Double Bottom Pattern? The MAK DailyThe chart of TRACON Pharmaceuticals, Inc. (TCON) shows a double bottom with $0.58 target or 5.00 % below today's $0.61 share price. The 9 months chart ...
-
Nicolet Advisory Services LLC Invests $49,000 in TRACON Pharmaceuticals Inc (NASDAQ:TCON) Stock - Tech Know Bits
Posted: June 6th, 2019, 11:44am GMT
Nicolet Advisory Services LLC Invests $49,000 in TRACON Pharmaceuticals Inc (NASDAQ:TCON) Stock Tech Know BitsNicolet Advisory Services LLC bought a new position in shares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) in the 1st quarter, according to its most recent ...
-
Can Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Tomorrow be Different? The Stock Had Increase in Shorts - The MAK Daily
Posted: June 5th, 2019, 9:12pm GMT
Can Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Tomorrow be Different? The Stock Had Increase in Shorts The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered an increase of 73.68% in short interest. TCON's total short interest was 430200 shares in.
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Sellers Increased By 73.68% Their Shorts - Invest Tribune
Posted: June 5th, 2019, 7:10pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON) Sellers Increased By 73.68% Their Shorts Invest TribuneThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered an increase of 73.68% in short interest. TCON's total short interest was 430200 shares in.
-
BioPharmX Corporation (BPMX)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - Stocks Beat
Posted: June 4th, 2019, 8:32pm GMT
BioPharmX Corporation (BPMX)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Stocks BeatSince BioPharmX Corporation (NYSEAMERICAN:BPMX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are part of the Biotechnology industry, they are ...
-
Angiosarcomas Treatment Market Report 2018-2026 : Recent Study Including Regional Analysis, Applications, Growth Factors And Key Players - Gator Ledger
Posted: June 4th, 2019, 6:04pm GMT
Angiosarcomas Treatment Market Report 2018-2026 : Recent Study Including Regional Analysis, Applications, Growth Factors And Key Players Gator LedgerThe global Angiosarcomas Treatment Market research report thoroughly explains each and every aspect related to the Angiosarcomas Treatment Market, which ...
-
Oncology Times - LWW Journals
Posted: June 4th, 2019, 3:22pm GMT
Oncology Times LWW JournalsCHICAGO—The POT1 gene is mutated in approximately 4 percent of chronic lymphocytic leukemia (CLL) patients. Recent studies have reported germline ...
-
Oncology Times - LWW Journals
Posted: June 4th, 2019, 3:22pm GMT
Oncology Times LWW JournalsCHICAGO—The POT1 gene is mutated in approximately 4 percent of chronic lymphocytic leukemia (CLL) patients. Recent studies have reported germline ...
-
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share - Tech Know Bits
Posted: June 3rd, 2019, 10:45am GMT
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share Tech Know BitsWall Street brokerages forecast that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings per share (EPS) of ($0.20) for the current quarter, ...
-
Nathan Christian Waite Jr. | Obituaries | journalstar.com - Lincoln Journal Star
Posted: June 2nd, 2019, 3:00am GMT
Nathan Christian Waite Jr. | Obituaries | journalstar.com Lincoln Journal StarMay 31, 2019. Nathan Christian Waite Jr. died on May 31st, 2019. Christian LIVED this last year battling a rare angiosarcoma. He was twelve years old.
-
Acasti Pharma Inc. (ACST) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side - CryptoCoinsTribune
Posted: June 1st, 2019, 9:02am GMT
Acasti Pharma Inc. (ACST) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side CryptoCoinsTribuneBoth Acasti Pharma Inc. (NASDAQ:ACST) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete on a level playing field in the Biotechnology industry.
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Seattle Genetics Inc. (NASDAQ:SGEN) - CryptoCoinsTribune
Posted: June 1st, 2019, 9:02am GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Seattle Genetics Inc. (NASDAQ:SGEN) CryptoCoinsTribuneTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Seattle Genetics Inc. (NASDAQ:SGEN) compete against each other in the Biotechnology sector. We will ...
-
Reviewing Rhythm Pharmaceuticals Inc. (RYTM)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - CryptoCoinsTribune
Posted: May 31st, 2019, 9:00pm GMT
Reviewing Rhythm Pharmaceuticals Inc. (RYTM)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results CryptoCoinsTribuneSince Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are part of the Biotechnology industry, they are ...
-
CBD Still Works for Me: A Follow-up - Curetoday.com
Posted: May 31st, 2019, 1:14pm GMT
CBD Still Works for Me: A Follow-up Curetoday.comRecently, I had my first experience with CBD oil and wrote a post about it on my blog. That was almost two months ago. Since that time, I've learned a lot more ...
-
Angiosarcomas Treatment Market Adoption of Innovative Offerings and Forecast 2018-2026 - Business Herald
Posted: May 31st, 2019, 9:29am GMT
Angiosarcomas Treatment Market Adoption of Innovative Offerings and Forecast 2018-2026 Business HeraldAngiosarcomas Treatment Market Research focuses on the key trends prevailing in the Global Angiosarcomas Treatment Industry sector. The existing ...
-
Ascendis Pharma A/S (ASND)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - CryptoCoinsTribune
Posted: May 31st, 2019, 8:48am GMT
Ascendis Pharma A/S (ASND)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) CryptoCoinsTribuneAs Biotechnology companies, Ascendis Pharma A/S (NASDAQ:ASND) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are our subject to contrast.
-
TRACON Pharmaceuticals (NASDAQ:TCON) Posts Earnings Results, Misses Expectations By $0.03 EPS - Mayfield Recorder
Posted: May 31st, 2019, 5:42am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Posts Earnings Results, Misses Expectations By $0.03 EPS Mayfield RecorderTRACON Pharmaceuticals (NASDAQ:TCON) announced its quarterly earnings data on Tuesday, May 14th. The biopharmaceutical company reported ($0.24) ...
-
Akebia Therapeutics Inc. (AKBA) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side - FinanceRecorder
Posted: May 31st, 2019, 1:01am GMT
Akebia Therapeutics Inc. (AKBA) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side FinanceRecorderBoth Akebia Therapeutics Inc. (NASDAQ:AKBA) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are each other's competitor in the Biotechnology industry.
-
Athenex, Inc. (ATNX) Reaches $14.40 After 8.00% Up Move; Independent Bank Has 1.91 Sentiment - CryptoCoinsTribune
Posted: May 30th, 2019, 2:47pm GMT
Athenex, Inc. (ATNX) Reaches $14.40 After 8.00% Up Move; Independent Bank Has 1.91 Sentiment CryptoCoinsTribuneThe stock of Athenex, Inc. (NASDAQ:ATNX) is a huge mover today! The stock increased 3.45% or $0.48 during the last trading session, reaching $14.4.
-
Cancer Destroyed My Figure so I Ate to Comfort Myself - Curetoday.com
Posted: May 30th, 2019, 12:50pm GMT
Cancer Destroyed My Figure so I Ate to Comfort Myself Curetoday.comMy surgery to remove my left breast implant is scheduled for June 27. I'm having the implant removed because back in 2016, they removed the right implant ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Earnings Results, Misses Expectations By $0.03 EPS - Tech Know Bits
Posted: May 30th, 2019, 7:19am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Earnings Results, Misses Expectations By $0.03 EPS Tech Know BitsTRACON Pharmaceuticals (NASDAQ:TCON) released its quarterly earnings data on Tuesday, May 14th. The biopharmaceutical company reported ($0.24) ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) - CryptoCoinsTribune
Posted: May 29th, 2019, 8:39pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) CryptoCoinsTribuneAs Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) are our subject to ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Zosano Pharma Corporation (NASDAQ:ZSAN)'s results - CryptoCoinsTribune
Posted: May 29th, 2019, 8:39pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Zosano Pharma Corporation (NASDAQ:ZSAN)'s results CryptoCoinsTribuneBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Zosano Pharma Corporation (NASDAQ:ZSAN) are each other's competitor in the Biotechnology ...
-
Angiosarcomas Treatment Market – See Incredible Growth, Analysis and Forecast 2018-2026 - Oak Tribune
Posted: May 29th, 2019, 10:37pm GMT
Angiosarcomas Treatment Market – See Incredible Growth, Analysis and Forecast 2018-2026 Oak TribuneLatest Research Report on Angiosarcomas Treatment Market begins with a deep introduction and then delves broad into specific segments such as raw material ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Verastem Inc. (NASDAQ:VSTM) - CryptoCoinsTribune
Posted: May 28th, 2019, 9:32am GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Verastem Inc. (NASDAQ:VSTM) CryptoCoinsTribuneTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Verastem Inc. (NASDAQ:VSTM), are influenced by contrast since they are both players in the ...
-
Adial Pharmaceuticals Inc. (ADIL)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - CryptoCoinsTribune
Posted: May 27th, 2019, 12:16pm GMT
Adial Pharmaceuticals Inc. (ADIL)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) CryptoCoinsTribuneThis is therefore a comparing of the institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation in Adial.
-
Angiosarcomas Treatment Market – Applications, Business Strategy and Forecast 2018-2026 - Truth Daily Mirror
Posted: May 27th, 2019, 10:37pm GMT
Angiosarcomas Treatment Market – Applications, Business Strategy and Forecast 2018-2026 Truth Daily MirrorThe Angiosarcomas Treatment Market report provides insightful details on how clients enhance their basic leadership capacity within the worldwide ...
-
uniQure NV (QURE)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - CryptoCoinsTribune
Posted: May 26th, 2019, 8:13pm GMT
uniQure NV (QURE)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) CryptoCoinsTribuneBoth uniQure N.V. (NASDAQ:QURE) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) compete on a level playing field in the Biotechnology industry.
-
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share - Tech Know Bits
Posted: May 26th, 2019, 4:43pm GMT
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share Tech Know BitsWall Street brokerages forecast that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings per share (EPS) of ($0.20) for the current quarter, ...
-
Gilead Sciences (GILD) vs. TRACON Pharmaceuticals (TCON) Critical Review - Tech Know Bits
Posted: May 25th, 2019, 12:28am GMT
Gilead Sciences (GILD) vs. TRACON Pharmaceuticals (TCON) Critical Review Tech Know BitsTRACON Pharmaceuticals (NASDAQ:TCON) and Gilead Sciences (NASDAQ:GILD) are both medical companies, but which is the superior business? We will ...
-
Comparison of CRISPR Therapeutics AG (CRSP) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The NBO News
Posted: May 24th, 2019, 8:48am GMT
Comparison of CRISPR Therapeutics AG (CRSP) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The NBO NewsCRISPR Therapeutics AG (NASDAQ:CRSP) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), both competing one another are Biotechnology companies.
-
DBV Technologies SA (DBVT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side - The EN Herald
Posted: May 24th, 2019, 10:53pm GMT
DBV Technologies SA (DBVT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side The EN HeraldThis is a contrast between DBV Technologies S.A. (NASDAQ:DBVT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) based on their institutional ownership ...
-
Zacks: Brokerages Anticipate TRACON Pharmaceuticals Inc (TCON) to Post -$0.19 Earnings Per Share - Mayfield Recorder
Posted: May 23rd, 2019, 9:11pm GMT
Zacks: Brokerages Anticipate TRACON Pharmaceuticals Inc (TCON) to Post -$0.19 Earnings Per Share Mayfield RecorderWall Street brokerages expect that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will announce earnings of ($0.19) per share for the current quarter, ...
-
TRACON Pharmaceuticals Inc. (TCON) and Its Competitors Financial Results Comparison - CryptoCoinsTribune
Posted: May 23rd, 2019, 1:27pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Its Competitors Financial Results Comparison CryptoCoinsTribuneWe are contrasting TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and its rivals on their risk, analyst recommendations, profitability, dividends, earnings and.
-
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Earnings Results, Misses Expectations By $0.03 EPS - Mayfield Recorder
Posted: May 23rd, 2019, 11:42am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Releases Earnings Results, Misses Expectations By $0.03 EPS Mayfield RecorderTRACON Pharmaceuticals (NASDAQ:TCON) issued its earnings results on Tuesday, May 14th. The biopharmaceutical company reported ($0.24) earnings per ...
-
Angiosarcomas Treatment Market Epoxy Curing Agents Progresses for Huge Profits by 2026 - Plains Gazette
Posted: May 23rd, 2019, 11:02am GMT
Angiosarcomas Treatment Market Epoxy Curing Agents Progresses for Huge Profits by 2026 Plains GazetteAn informative study on the Angiosarcomas Treatment market from 2018-2026 has lately released for the database of Coherent Market Insights that helps by ...
-
Adapting for success - pharmaphorum
Posted: May 23rd, 2019, 6:48am GMT
Adapting for success pharmaphorumTRACON Pharmaceuticals' president and CEO Charles Theuer on changes in oncology and cancer trials, and how his firm is keeping pace.
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Kura Oncology Inc. (NASDAQ:KURA) - The NBO News
Posted: May 22nd, 2019, 8:24pm GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Kura Oncology Inc. (NASDAQ:KURA) The NBO NewsAs Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Kura Oncology Inc. (NASDAQ:KURA) are our subject to contrast. And more ...
-
Liver Cancer Molecular Diagnostics Market Size, Share | Industry Report 2025 - openPR
Posted: May 22nd, 2019, 12:07pm GMT
Liver Cancer Molecular Diagnostics Market Size, Share | Industry Report 2025 openPRThe global liver cancer molecular diagnostics market was valued at $115.3 Million in 2017 and is forecast to grow at a modest 13.7 % CAGR between 2018 and ...
-
Angiosarcomas Treatment Market: Adoption of Innovative Offerings To Boost Returns On Investment - Gator Ledger
Posted: May 22nd, 2019, 11:27am GMT
Angiosarcomas Treatment Market: Adoption of Innovative Offerings To Boost Returns On Investment Gator LedgerIndustrial Growth Forecast Report Playground Angiosarcomas Treatment Market 2018-2026: The Global Angiosarcomas Treatment Market Report provides ...
-
TRACON Pharmaceuticals (TCON) Shares Up 5% - Tech Know Bits
Posted: May 22nd, 2019, 10:18am GMT
TRACON Pharmaceuticals (TCON) Shares Up 5% Tech Know BitsTRACON Pharmaceuticals Inc (NASDAQ:TCON)'s share price shot up 5% on Monday . The stock traded as high as $0.85 and last traded at $0.84. 5294 shares ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Axsome Therapeutics Inc. (NASDAQ:AXSM) - CryptoCoinsTribune
Posted: May 22nd, 2019, 4:52am GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Axsome Therapeutics Inc. (NASDAQ:AXSM) CryptoCoinsTribuneThis is a contrast between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Axsome Therapeutics Inc. (NASDAQ:AXSM) based on their institutional ...
-
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With BeyondSpring Inc. (NASDAQ:BYSI) - The EN Herald
Posted: May 22nd, 2019, 10:43pm GMT
TRACON Pharmaceuticals Inc. (TCON)'s Financial Results Comparing With BeyondSpring Inc. (NASDAQ:BYSI) The EN HeraldTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and BeyondSpring Inc. (NASDAQ:BYSI), are influenced by compare since they are both players in the ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Fortress Biotech Inc. (NASDAQ:FBIO) - CryptoCoinsTribune
Posted: May 21st, 2019, 8:30pm GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Fortress Biotech Inc. (NASDAQ:FBIO) CryptoCoinsTribuneAs Biotechnology companies, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Fortress Biotech Inc. (NASDAQ:FBIO) are our subject to compare. And more ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Mirati Therapeutics Inc. (NASDAQ:MRTX)'s results - The EN Herald
Posted: May 21st, 2019, 5:18pm GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Mirati Therapeutics Inc. (NASDAQ:MRTX)'s results The EN HeraldSince TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Mirati Therapeutics Inc. (NASDAQ:MRTX) are part of the Biotechnology industry, they are influenced ...
-
Contrasting of Aclaris Therapeutics Inc. (ACRS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - The EN Herald
Posted: May 21st, 2019, 2:35pm GMT
Contrasting of Aclaris Therapeutics Inc. (ACRS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) The EN HeraldAclaris Therapeutics Inc. (NASDAQ:ACRS) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are two firms in the Biotechnology that compete against each ...
-
What Will Happen to TRACON Pharmaceuticals, Inc. (TCON) Next? The Stock Formed a Several Months Bearish Double Bottom Chart Pattern - The MAK Daily
Posted: May 21st, 2019, 8:48am GMT
What Will Happen to TRACON Pharmaceuticals, Inc. (TCON) Next? The Stock Formed a Several Months Bearish Double Bottom Chart Pattern The MAK DailyThe chart of TRACON Pharmaceuticals, Inc. (TCON) shows a double bottom with $0.70 target or 8.00 % below today's $0.76 share price. The 7 months chart ...
-
Angiosarcomas Treatment Market – Global Industry, Size, Share And Forecast 2018-2026 - Veteran's Vista
Posted: May 21st, 2019, 8:46am GMT
Angiosarcomas Treatment Market – Global Industry, Size, Share And Forecast 2018-2026 Veteran's VistaAngiosarcomas Treatment Market is drafted for providing the interested readers with the crucial information related to the Angiosarcomas Treatment industry.
-
Is Selling TRACON Pharmaceuticals, Inc. (TCON) Here a Winning Strategy? The Stock Formed Bearish Double Bottom Chart Pattern - Invest Tribune
Posted: May 21st, 2019, 8:24am GMT
Is Selling TRACON Pharmaceuticals, Inc. (TCON) Here a Winning Strategy? The Stock Formed Bearish Double Bottom Chart Pattern Invest TribuneThe chart of TRACON Pharmaceuticals, Inc. (TCON) shows a double bottom with $0.70 target or 8.00 % below today's $0.76 share price. The 7 months chart ...
-
New data on cancer disparities in Washington - Fred Hutch News Service
Posted: May 20th, 2019, 5:29pm GMT
New data on cancer disparities in Washington Fred Hutch News ServiceWhere a person lives has a big impact on whether they will live following a cancer diagnosis in our state, according to new data released by researchers at the ...
-
Reviewing Kodiak Sciences Inc. (KOD)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - CryptoCoinsTribune
Posted: May 20th, 2019, 5:06pm GMT
Reviewing Kodiak Sciences Inc. (KOD)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results CryptoCoinsTribuneKodiak Sciences Inc. (NASDAQ:KOD) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON), are influenced by compare since they are both players in the ...
-
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share - Tech Know Bits
Posted: May 19th, 2019, 4:43pm GMT
Analysts Anticipate TRACON Pharmaceuticals Inc (TCON) Will Post Earnings of -$0.20 Per Share Tech Know BitsWall Street brokerages forecast that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings per share (EPS) of ($0.20) for the current quarter, ...
-
TRACON Pharmaceuticals (TCON) Downgraded to “Sell” at Zacks Investment Research - Mayfield Recorder
Posted: May 19th, 2019, 12:31pm GMT
TRACON Pharmaceuticals (TCON) Downgraded to “Sell” at Zacks Investment Research Mayfield RecorderZacks Investment Research downgraded shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a sell rating in a research note issued to ...
-
TRACON Pharmaceuticals (TCON) Sees Strong Trading Volume - Mayfield Recorder
Posted: May 19th, 2019, 5:00am GMT
TRACON Pharmaceuticals (TCON) Sees Strong Trading Volume Mayfield RecorderTRACON Pharmaceuticals Inc (NASDAQ:TCON) saw an uptick in trading volume on Friday . 1008522 shares were traded during mid-day trading, an increase of ...
-
The TRACON Pharmaceuticals' (TCON) “Buy” Rating Restated at Needham & Company LLC - BharataPress
Posted: May 18th, 2019, 6:00pm GMT
The TRACON Pharmaceuticals' (TCON) “Buy” Rating Restated at Needham & Company LLC BharataPressTRACON Pharmaceuticals (NASDAQ:TCON)'s stock had its “buy” rating restated by Needham & Company LLC in a research note issued on Friday.
-
Zacks Investment Research Downgrades TRACON Pharmaceuticals (TCON) to Sell - Tech Know Bits
Posted: May 18th, 2019, 11:48am GMT
Zacks Investment Research Downgrades TRACON Pharmaceuticals (TCON) to Sell Tech Know BitsTRACON Pharmaceuticals (NASDAQ:TCON) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to ...
-
TRACON Pharmaceuticals Inc (TCON) Expected to Announce Earnings of -$0.19 Per Share - Mayfield Recorder
Posted: May 18th, 2019, 5:00am GMT
TRACON Pharmaceuticals Inc (TCON) Expected to Announce Earnings of -$0.19 Per Share Mayfield RecorderWall Street brokerages forecast that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings of ($0.19) per share for the current quarter, Zacks reports ...
-
TRACON Pharmaceuticals (TCON) Sees Large Volume Increase - Tech Know Bits
Posted: May 17th, 2019, 8:52pm GMT
TRACON Pharmaceuticals (TCON) Sees Large Volume Increase Tech Know BitsShares of TRACON Pharmaceuticals Inc (NASDAQ:TCON) saw unusually-high trading volume on Friday . Approximately 1008522 shares were traded during ...
-
Head-To-Head Comparison: TRACON Pharmaceuticals (TCON) vs. Gilead Sciences (GILD) - Tech Know Bits
Posted: May 17th, 2019, 6:25am GMT
Head-To-Head Comparison: TRACON Pharmaceuticals (TCON) vs. Gilead Sciences (GILD) Tech Know BitsGilead Sciences (NASDAQ:GILD) and TRACON Pharmaceuticals (NASDAQ:TCON) are both medical companies, but which is the better stock? We will contrast ...
-
TRACON Pharmaceuticals (TCON) Posts Earnings Results - Mayfield Recorder
Posted: May 16th, 2019, 11:41am GMT
TRACON Pharmaceuticals (TCON) Posts Earnings Results Mayfield RecorderTRACON Pharmaceuticals (NASDAQ:TCON) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.24) earnings per ...
-
-$0.16 Earnings Per Share Expected for TRACON Pharmaceuticals Inc (TCON) This Quarter - Rockland Register
Posted: May 16th, 2019, 10:09am GMT
-$0.16 Earnings Per Share Expected for TRACON Pharmaceuticals Inc (TCON) This Quarter Rockland RegisterWall Street brokerages predict that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will post earnings per share (EPS) of ($0.16) for the current fiscal quarter, ...
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Curis Inc. (NASDAQ:CRIS) - The EN Herald
Posted: May 16th, 2019, 9:13am GMT
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Curis Inc. (NASDAQ:CRIS) The EN HeraldWe are comparing TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Curis Inc. (NASDAQ:CRIS) on their profitability, analyst recommendations, risk, ...
-
Should Investors Turn Their Attention to Athenex (NASDAQ:ATNX)? BidaskScore Has Just Upgraded the Stock - The MAK Daily
Posted: May 16th, 2019, 5:00am GMT
Should Investors Turn Their Attention to Athenex (NASDAQ:ATNX)? BidaskScore Has Just Upgraded the Stock The MAK DailyTrading of shares of Athenex (NASDAQ:ATNX) will be interesting to watch this afternoon as BidaskScore raised the stock to a “Hold”. The stock increased 1.59% ...
-
Reviewing Equillium Inc. (EQ)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - The EN Herald
Posted: May 16th, 2019, 5:00am GMT
Reviewing Equillium Inc. (EQ)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results The EN HeraldSince Equillium Inc. (NASDAQ:EQ) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) are part of the Biotechnology industry, they are influenced by contrast.